Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Monday, September 1, 2025 in observance of the Labor Day holiday.  Have a healthy, happy holiday.

Hide
Quest Diagnostics

Assessment of Oxycodone and Metabolite Concentrations in Urine and Oral Fluid in Patients in Prescription Drug Monitoring Programs

SOFT 2021: Society of Forensic Toxicologists
Virtual Meeting, Sep 22-Sep 26, 2021

Poster presentation (virtual): Assessment of Oxycodone and Metabolite Concentrations in Urine and Oral Fluid in Patients in Prescription Drug Monitoring Programs

Authors: Chen L, Jenkins AJ

Specialties: prescription drug monitoring, toxicology, pain management

Related content

On-Demand Webinar
The Growing Crisis of Novel Psychoactive Substances
Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing
Audio Podcast
Drug Testing for Stimulants
Test FAQ
Novel Psychoactive Substances (NPS) Panel
Audio Podcast
The CDC Clinical Practice Guideline for Prescribing Opiods for Pain
Audio Podcast
Dangerous Drug Combinations
Test FAQ
Pain Management Antipsychotics With Confirmation Serum and Urine

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.